156 related articles for article (PubMed ID: 37487699)
1.
Maas EJ; Wallingford CK; DeBortoli E; Smit DJ; Betz-Stablein B; Aoude LG; Stark MS; Sturm RA; Soyer HP; McInerney-Leo AM
J Med Genet; 2023 Sep; 60(9):835-837. PubMed ID: 37487699
[No Abstract] [Full Text] [Related]
2. A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant Melanoma.
Teerlink CC; Huff C; Stevens J; Yu Y; Holmen SL; Silvis MR; Trombetti K; Zhao H; Grossman D; Farnham JM; Wen J; Facelli JC; Thomas A; Babst M; Florell SR; Meyer L; Zone JJ; Leachman S; Cannon-Albright LA
J Natl Cancer Inst; 2018 Dec; 110(12):1380-1385. PubMed ID: 29659923
[TBL] [Abstract][Full Text] [Related]
3. STAT3 activates the transcription of lncRNA NR2F1-AS1 to promote the progression of melanoma via regulating the miR-493-5p/GOLM1 axis.
Bai M; Wu ZZ; Huang YL; Ke J; Xu Q; Wang X
J Gene Med; 2021 Jul; 23(7):e3338. PubMed ID: 33822440
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells.
Kong Y; Kumar SM; Xu X
Arch Pathol Lab Med; 2010 Dec; 134(12):1740-9. PubMed ID: 21128770
[TBL] [Abstract][Full Text] [Related]
5. Unfolding the mutational landscape of human melanoma.
Davar D; Lin Y; Kirkwood JM
J Invest Dermatol; 2015 Mar; 135(3):659-662. PubMed ID: 25666674
[TBL] [Abstract][Full Text] [Related]
6. The genetics of melanoma.
Bishop JN; Harland M; Bishop DT
Br J Hosp Med (Lond); 2006 Jun; 67(6):299-304. PubMed ID: 16821732
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics-based analysis reveals elevated MFSD12 as a key promoter of cell proliferation and a potential therapeutic target in melanoma.
Wei CY; Zhu MX; Lu NH; Peng R; Yang X; Zhang PF; Wang L; Gu JY
Oncogene; 2019 Mar; 38(11):1876-1891. PubMed ID: 30385854
[TBL] [Abstract][Full Text] [Related]
8. Integrative genetic analysis suggests that skin color modifies the genetic architecture of melanoma.
Hulur I; Skol AD; Gamazon ER; Cox NJ; Onel K
PLoS One; 2017; 12(10):e0185730. PubMed ID: 28973033
[TBL] [Abstract][Full Text] [Related]
9. A report of malignant melanoma of the skin in sisters.
MOSCHELLA SL
Arch Dermatol; 1961 Dec; 84():1024-5. PubMed ID: 14476423
[No Abstract] [Full Text] [Related]
10. Cutaneous melanoma susceptibility and progression genes.
de Snoo FA; Hayward NK
Cancer Lett; 2005 Dec; 230(2):153-86. PubMed ID: 16297704
[TBL] [Abstract][Full Text] [Related]
11. Genetics of familial atypical multiple mole-melanoma (FAMMM) syndrome in The Netherlands: how far have we come?
Gruis NA; Van der Velden PA; Bergman W; Frants RR
Bull Cancer; 1998 Jul; 85(7):627-30. PubMed ID: 9752270
[TBL] [Abstract][Full Text] [Related]
12. Genetics of cutaneous melanoma.
Meyer LJ; Zone JH
J Invest Dermatol; 1994 Nov; 103(5 Suppl):112S-116S. PubMed ID: 7963671
[TBL] [Abstract][Full Text] [Related]
13. Melanoma susceptibility genes.
Newton-Bishop J; Gruis N
Melanoma Res; 2010 Jun; 20(3):161-2. PubMed ID: 20442621
[No Abstract] [Full Text] [Related]
14. Genetics of melanoma susceptibility.
Ghiorzo P; Scarrà GB
Forum (Genova); 2003; 13(2):114-22; quiz 187. PubMed ID: 14732879
[TBL] [Abstract][Full Text] [Related]
15. Low Levels of Genetic Heterogeneity in Matched Lymph Node Metastases from Patients with Melanoma.
Casula M; Colombino M; Manca A; Caracò C; Botti G; Ascierto PA; Lissia A; Cossu A; Palmieri G;
J Invest Dermatol; 2016 Sep; 136(9):1917-1920. PubMed ID: 27265006
[No Abstract] [Full Text] [Related]
16. [Recurrent somatic activating RAC1 mutations in melanoma].
Dereure O
Ann Dermatol Venereol; 2012 Nov; 139(11):785-6. PubMed ID: 23199784
[No Abstract] [Full Text] [Related]
17. Targeting GOLM1 by microRNA-200a in melanoma suppresses cell proliferation, invasion and migration via regulating PI3K/Akt signaling pathway and epithelial-mesenchymal transition.
Chen WY; Xu YY; Zhang XY
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6997-7007. PubMed ID: 31486500
[TBL] [Abstract][Full Text] [Related]
18. Genetics of melanoma progression: the rise and fall of cell senescence.
Bennett DC
Pigment Cell Melanoma Res; 2016 Mar; 29(2):122-40. PubMed ID: 26386262
[TBL] [Abstract][Full Text] [Related]
19. Role of Genetics and Epigenetics in Mucosal, Uveal, and Cutaneous Melanomagenesis.
Venza M; Visalli M; Beninati C; Biondo C; Teti D; Venza I
Anticancer Agents Med Chem; 2016; 16(5):528-38. PubMed ID: 26234362
[TBL] [Abstract][Full Text] [Related]
20. The genetics of susceptibility to cutaneous melanoma.
Newton Bishop JA; Bishop DT
Drugs Today (Barc); 2005 Mar; 41(3):193-203. PubMed ID: 15883616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
